/ VNDA
Why Is VNDA Stock Surging Premarket? FDA Approves Motion Sickness Drug
Vanda Pharmaceuticals stock surged nearly 19% in premarket trading after receiving FDA approval for NEREUS, the first new motion sickness treatment in over 40 ...
December 31, 2025